- cafead May 16, 2024 at 12:02: PM
via Biopharma mergers and acquisitions (M&A) activity is ratcheting back up following a downturn in 2022 and 2023.
Biopharma M&A have increased by 71% year-over-year during the first quarter of 2024, according to a report out of GlobalData this week.
article source
Biopharma M&A have increased by 71% year-over-year during the first quarter of 2024, according to a report out of GlobalData this week.
article source